• Nyxoah SA NYXH.BR reported a quarterly adjusted loss of 60 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -41 cents. The mean expectation of five analysts for the quarter was for a loss of 48 cents per share. Wall Street expected results to range from -57 cents to -40 cents per share.

• Revenue fell 12.9% to €1.06 million from a year ago; analysts expected €1.61 million.

• Nyxoah SA's reported EPS for the quarter was a loss of 60 cents​.

• The company reported a quarterly loss of €22.38 million.

• Nyxoah SA shares had fallen by 17.2% this quarter and lost 27.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 37.9% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

• Wall Street's median 12-month price target for Nyxoah SA is $15.00

This summary was machine generated from LSEG data May 14 at 11:59 a.m. UTC. ​All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)